LAAO with Watchman Device Post-Procedure Best Practices

Slides:



Advertisements
Similar presentations
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Advertisements

Delayed Common Post-operative complications occurred after LAAO Dr. Iat-Lon,Leong Department of Medicine, Division of Cardiology Macau Kiang Wu Hospital.
PROTECT-AF (LAA Closure with Watchman vs Warfarin in AF and Stroke) A long-term (45-month) follow-up analysis of device therapy with Watchman vs warfarin.
Cost-Effectiveness of Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis Compared with Surgical Aortic Valve Replacement in High Risk.
Medication History: Keeping our patients safe. How do we get all of the correct details?
One Year Outcomes in Real World Patients Treated with Transcatheter Aortic Valve Implantation The ADVANCE Study Axel Linke University of Leipzig Heart.
Atrial Fibrillation Warfarin and its newer alternatives
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
The Risk and Extent of Neurological Events Are Equivalent for High-Risk Patients Treated With Transcatheter or Surgical Aortic Valve Replacement Thomas.
Template Title Speaker Name Subtitle. Disclosure Statement of Financial Interest Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity.
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
On the CUSP: STOP BSI Improving Situational Awareness by Conducting a Morning Briefing.
On the CUSP: STOP BSI Improving Situational Awareness by Conducting a Morning Briefing.
Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Stable Coronary Disease: Results from the FAME.
Title of Presentation Presenter Name, Designation Presenter 2 Name, Designation Presenter 3 Name, Designation.
CIT 2016 Template Title 40 pt Bold Arial David Liu, MD Subtitle 34 pt Arial Bold Italics.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Strategies to Improve Inadequate Guide Catheter Support John S Douglas Jr MD S Tanveer Rab MD Emory University School of Medicine Atlanta Georgia Sunday.
Disclosure Statement of Financial Interest
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
SCRIPPS CLINIC A Cost Analysis of Bleed Complications from Two Stroke Prevention Strategies in Non-valvular Atrial Fibrillation: Left Atrial Appendage.
Final 5 year results from the all-comer COMPARE trial: a prospective randomized comparison between Xience-V and Taxus Liberté TCT 2013 San Francisco Pieter.
© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.
Disclosure Statement of Financial Interest Saibal Kar, MD, FACC
Disclosure Statement of Financial Interest
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Rachel Neubrander, PhD Division of Cardiovascular Devices
Essentials of Quality Control
LAAC: What Does the Post Marketing Data Tell Us?
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Cangrelor Case Presentations
Case Selection and Patient Throughput Techniques
Update on the Watchman Device CRT 2010 Washington, DC
University at Buffalo Neurosurgery
CRT 2017: Putting LAA closure in the age of DOACs into perspective
Jeff Shuren, MD, JD Center for Devices and Radiological Health U. S
Catheter-Based Options for Treating PE
Claret Cerebral Protection Device: Implications of the Sentinel Study
Renal Denervation Next Steps
David R. Holmes, Jr., M.D. Mayo Clinic, Rochester
Optimizing Valve Sizing: Role of CT vs. Echo
Polypharmacy Anticoagulation: AF meets PCI
Medtronic Cardiovascular,
Surgical Mitral Valve Repair: What is the Gold Standard?
Gates Vascular Institute
Disclosure Statement of Financial Interest
Ramon Quesada, MD, FACP,FACC, FSCAI,
TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS,
Percutaneous Device Occlusions for Left Atrial Appendage (LAA)
ACTIVE A Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists.
Up to Date on Which NOAC for Which Patient
CIT 2018 Template Title 40 pt Bold Arial
A Randomized, Prospective, Intercontinental Evaluation of a Bioresorbable Polymer Sirolimus-eluting Stent: the CENTURY II Trial: an Update with 2 Years.
Significant (greater than $10K)
CIT 2018 Template Title 40 pt Bold Arial
Left atrial appendage closure: A new technique for clinical practice
Watching for the Patient With AF: Latest Advances and Technologies
CIT 2017 Template Title 40 pt Bold Arial
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
A typical day on the inpatient Medicine team What do I need to know?
CIT 2017 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Title 40pt Trebuchet MS Bold
Disclosure Statement of Financial Interest
Disclosure Statement of Financial Interest
Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation  David R. Holmes, MD, Mohamad Alkhouli,
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
MOST Study Update and Protocol Refresher
CIT 2018 Template Title 40 pt Bold Arial
Presentation transcript:

LAAO with Watchman Device Post-Procedure Best Practices Lindsay Thomas, MS, RN, CCNS

Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company Names

LAAO Watchman Post-Procedure Best Practices Inpatient Services Post-Procedure Pharmacotherapy & Testing Post-Procedure Quality of Life LAAO Example documents & templates

Inpatient LAAO Services Dedicated service to facilitate management of the LAAO patient population Standardized protocols for post-procedural management Include key members of multidisciplinary heart team: physicians, PAs, NPs, CNSs, RNs, Fellows, quality, IT… Utilize electronic health resources Continued communication with referring physicians RN staff education: in-services/training

Inpatient LAAO Services Significant learning curve that accompanies LAAO procedures Operator and team should be capable of handling potential complications, while receiving units/nurses should be competent to recognize and react to potential complications Hematoma/vascular injury Pericardial effusion/tamponade Device embolization Stroke

LAAO Standardized Procedures Post-Procedure Orders Determine who will place orders (may want to create cheat sheet) Physician, Fellow, PA/NP/CNS Admit to cardiology service overnight Initiate aspirin & warfarin (low dose) Prophylactic antibiotics Cefazolin 1 gm IV : <1 hr pre-procedure and 12hr post-procedure TTE prior to discharge Assess for pericardial effusion, confirm device placement, and absence of intracardiac thrombus

LAAO Patient Discharge Patient Education & Follow Up No lifting >20 lbs x 3 days, avoid strenuous activity x 1 week Make sure patient receives, “Watchman Left Atrial Appendage Closure Device Patient Information Guide” Watchman Device Wallet Card Reinforce warfarin education and INR schedule Provide lab orders if needed If previously on NOAC confirm patient understands NOT to resume Review when to call MD/RN and provide contact information Schedule follow up TEE and clinic visit

LAAO Post-Procedure Pharmacotherapy & Follow Up POD 1 POD 45 PO 6 mo Pharmaco-therapy aspirin 81-100 mg warfarin *prophylactic antibiotics prn aspirin 300-325 mg clopidogrel 75 mg Aspirin 300-325 mg indefinitely *prophylactic antibiotics Diagnostic Testing TTE: assess device placement and absence of thrombus TEE: assess device placement, absence of thrombus, and leak (≤5 mm) prn Follow up Discharge home: INR lab orders, f/u appointments scheduled Clinic Visit

Contraindication to Anticoagulation Is LAAO in the future for patients who are unable to be treated with OAC due to major contraindications or intolerance?

45-day TEE & Visit Confirm absence of intra-cardiac thrombus Assess Watchman device with TEE Confirm absence of intra-cardiac thrombus If thrombus present recommend continuing warfarin until resolution of thrombus Perform color doppler assessment at TEE angles (0°, 45°, 90°, & 135°) to assess for leak If leak > 5mm continuation of warfarin recommended Clinic visit assess for any bleeding events or neurologic changes Utilize Barthel Index or Modified Rankin Scale to measure disability in patients who have suffered CVA

LAAO Quality of Life Sub-analysis of PROTECT AF trial to measure quality of life Short-Form 12 Health Survey obtained at baseline and at 12 months At 12 months, patients who received Watchman device showed improvements in total physical score, physical functioning, and physical role limitations, while warfarin patients experienced decreases Significant improvement in QOL in patients randomized to device compared to control No More warfarin = better QOL “By taking them off the warfarin, these patients feel great, they eat better, exercise more, and could walk better without the fear of falling and having a bleed.” Ziyad M. Hijazi, MD, MPH

LAAO Work Flow & Responsibilities Example of LAAO work flow to outline and define LAAO team responsibilities Individualize to your team and institution Modify as needed as program evolves

LAAO Cheat Sheet Single page summary provided to all fellows/residents who will provide care to LAAO patients

Standardize LAAO Orders Example: POD 45 standardized TEE order: information included in comments section to make sure all important measurements are taken

Questions? Thanks for your attention.